Evidence map›Paper›PMID 35511397›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2022

An effective algorithm to detect the possibility of being MSI phenotype in endometrial cancer given the BMI status and histological subtype: a statistical study.

Isabel González Villa, Enrique Francisco González Dávila, Idaira Jael Expósito Afonso, Leynis Isabel Martínez Blanco, Juan Francisco Loro Ferrer, Juan José Cabrera Galván

Open access · hybridAbstract read
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Isabel González VillaPathological Anatomy Service, Canary University Hospital, Tenerife, Spain.
Enrique Francisco González DávilaDepartment of Mathematics, Statistics and Operations Research, University of La Laguna, Tenerife, Spain.ORCID https://orcid.org/0000-0002-0781-9161
Idaira Jael Expósito AfonsoPathological Anatomy Service, Nuestra Señora de Candelaria University Hospital, Canary Islands Health Service, Tenerife, Spain.
Leynis Isabel Martínez BlancoPathological Anatomy Service, Nuestra Señora de Candelaria University Hospital, Canary Islands Health Service, Tenerife, Spain.
Juan Francisco Loro FerrerDepartment of Clinical Sciences, Faculty of Health Sciences, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.ORCID https://orcid.org/0000-0002-0517-8209
Juan José Cabrera GalvánPathological Anatomy Unit, Morphology Department, University Institute for Biomedical and Health Research (IUIBIS), University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain. juanjose.cabrera@ulpgc.es.ORCID https://orcid.org/0000-0002-4184-6403
Universidad de Las Palmas de Gran Canaria · ESUniversidad de La Laguna · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn endometrial cancer, the incidence of mutations in mismatch repair genes (MMR) is estimated at 17-30%. Patients with alterations at this level (MSI) are known to have different clinical and anatomopathological characteristics than those without this genetic alteration (MSS). In this study, we aim to identify the MSI phenotype in patients who underwent hysterectomy for endometrial cancer. We assessed the correlation of this phenotype with anatomoclinical parameters such as obesity and histological subtype. METHODS/PATIENTS: Clinical and anatomopathological data were collected from 147 patients diagnosed with endometrial cancer and an immunohistochemical study of MMR system proteins was performed. PMS2 and MSH6 proteins were evaluated as primary screening and subsequent evaluation of MLH1 and MSH6, respectively, if the former were negative. Statistical association between the anatomopathological data and the immunohistochemical result was analyzed. RESULTS AND

conclusions22.4% of our patients were MSI phenotype. We obtained statistically significant differences by multivariate analysis between endometrioid subtype and higher FIGO classification grade with MSI phenotype and obesity with MSS phenotype. Given these statistical results, we propose a function for predicting the probability of being MSI phenotype taking into account the histological subtype (endometrioid/non-endometrioid carcinoma) and FIGO grade as well as obesity. This prediction may be useful prior to hysterectomy, for genetic study of the MLH1 promoter and subsequent genetic counseling.

Indexed as

Carcinoma, EndometrioidEndometrial NeoplasmsAlgorithmsBody Mass IndexFemaleHumansMicrosatellite InstabilityMutL Protein Homolog 1MutS Homolog 2 ProteinObesityPhenotypeMutL Protein Homolog 1MutS Homolog 2 ProteinBody mass indexDNA mismatch repair deficiencyEndometrial neoplasmsImmunohistochemistryMSI phenotype

Identifiers

PMID35511397
PMCPMC9338113
OpenAlexW4229055285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.